🇺🇸 FDA
Patent

US 9493833

Methods for preventing induced synthesis of proteasomes in human cells

granted A61KA61K31/5355A61K31/7088

Quick answer

US patent 9493833 (Methods for preventing induced synthesis of proteasomes in human cells) held by The Regents of the University of California expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/5355, A61K31/7088, A61K31/7105, A61K38/00